CLINICAL_TRIALS trial_result · 2009-08-24

Clinical Trial Update: A Trial for Patients With Advanced/Recurrent Endometrial Cancer [Phase 2]

A Phase 2 trial evaluating treatment for advanced or recurrent endometrial cancer has completed. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Neoplasms by Site | Phase 2 | Status: COMPLETED | Results posted: 2009-08-24